ExamWorks Group Inc

Find Ratings Reports
EXAM : : Financial
$35.07 -0.10 | -0.28%
Today's Range: 35.05 - 35.17
Avg. Daily Volume: 884,900
07/27/16 - 10:39 AM ET

Financial Analysis


EXAMWORKS GROUP INC's gross profit margin for the first quarter of its fiscal year 2016 is essentially unchanged when compared to the same period a year ago. The company managed to grow both sales and net income at a faster pace than the average competitor in its industry this quarter as compared to the same quarter a year ago. EXAMWORKS GROUP INC has strong liquidity. Currently, the Quick Ratio is 1.79 which shows the ability to cover short-term cash needs. The company managed to increase its liquidity from the same period a year ago, despite already having strong liquidity to begin with. This would indicate improved cash flow.

At the same time, stockholders' equity ("net worth") has remained virtually unchanged only increasing by 1.70% from the same quarter last year. The key liquidity measurements indicate that the company is unlikely to face financial difficulties in the near future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q1 FY16 Q1 FY15
Net Sales ($mil)226.5196.32
EBITDA ($mil)32.0727.94
EBIT ($mil)15.4313.1
Net Income ($mil)3.262.02


Balance Sheet Q1 FY16 Q1 FY15
Cash & Equiv. ($mil)16.020.28
Total Assets ($mil)1113.76943.76
Total Debt ($mil)575.94428.45
Equity ($mil)367.31361.15


Profitability Q1 FY16 Q1 FY15
Gross Profit Margin34.1634.71
EBITDA Margin14.1514.23
Operating Margin6.816.67
Sales Turnover0.760.85
Return on Assets0.611.35
Return on Equity1.853.54
Debt Q1 FY16 Q1 FY15
Current Ratio1.931.85
Debt/Capital0.610.54
Interest Expense8.47.94
Interest Coverage1.841.65


Share Data Q1 FY16 Q1 FY15
Shares outstanding (mil)41.2141.28
Div / share0.00.0
EPS0.080.05
Book value / share8.918.75
Institutional Own % n/a n/a
Avg Daily Volume907608.0371440.0

Valuation


HOLD. EXAMWORKS GROUP INC's P/E ratio indicates a significant premium compared to an average of 21.90 for the Health Care Providers & Services industry and a significant premium compared to the S&P 500 average of 25.05. For additional comparison, its price-to-book ratio of 3.93 indicates a premium versus the S&P 500 average of 2.81 and a premium versus the industry average of 3.34. The price-to-sales ratio is below the S&P 500 average, but well above the industry average. Upon assessment of these and other key valuation criteria, EXAMWORKS GROUP INC proves to trade at a premium to investment alternatives within the industry.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
EXAM 219.13 Peers 21.90   EXAM 24.26 Peers 12.23

Premium. A higher P/E ratio than its peers can signify a more expensive stock or higher growth expectations.

EXAM is trading at a significant premium to its peers.

 

Premium. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

EXAM is trading at a significant premium to its peers.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
EXAM 40.77 Peers 16.46   EXAM 0.66 Peers 0.95

Premium. A higher price-to-projected earnings ratio than its peers can signify a more expensive stock or higher future growth expectations.

EXAM is trading at a significant premium to its peers.

 

Discount. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

EXAM trades at a significant discount to its peers.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
EXAM 3.93 Peers 3.34   EXAM -48.39 Peers 22.01

Premium. A higher price-to-book ratio makes a stock less attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

EXAM is trading at a premium to its peers.

 

Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

However, EXAM is expected to significantly trail its peers on the basis of its earnings growth rate.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
EXAM 1.70 Peers 0.81   EXAM 6.36 Peers 14.30

Premium. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

EXAM is trading at a significant premium to its industry.

 

Lower. A sales growth rate that trails the industry implies that a company is losing market share.

EXAM significantly trails its peers on the basis of sales growth

 

 

Latest Stock Upgrades/Downgrades